SLC23A3
gene geneOn this page
Also known as SVCT3FLJ31168Yspl1
Summary
SLC23A3 (solute carrier family 23 member 3, HGNC:20601) is a protein-coding gene on chromosome 2q35, encoding Solute carrier family 23 member 3 (Q6PIS1). Acts as a sodium-dependent hypoxanthine transporter.
Predicted to enable transmembrane transporter activity. Involved in hypoxanthine transport. Predicted to be located in membrane.
Source: NCBI Gene 151295 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 85 total
- MANE Select transcript:
NM_001144889
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20601 |
| Approved symbol | SLC23A3 |
| Name | solute carrier family 23 member 3 |
| Location | 2q35 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SVCT3, FLJ31168, Yspl1 |
| Ensembl gene | ENSG00000213901 |
| Ensembl biotype | protein_coding |
| OMIM | 620339 |
| Entrez | 151295 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 7 protein_coding, 3 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000295738, ENST00000409370, ENST00000409878, ENST00000414999, ENST00000421779, ENST00000430764, ENST00000455516, ENST00000461812, ENST00000465580, ENST00000497918, ENST00000858810, ENST00000858811
RefSeq mRNA: 3 — MANE Select: NM_001144889
NM_001144889, NM_001144890, NM_144712
CCDS: CCDS42819, CCDS46517, CCDS46518
Canonical transcript exons
ENST00000409878 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001581895 | 219165169 | 219165422 |
| ENSE00001828902 | 219169823 | 219170029 |
| ENSE00003465693 | 219169521 | 219169678 |
| ENSE00003489814 | 219169309 | 219169406 |
| ENSE00003513185 | 219162299 | 219162394 |
| ENSE00003536644 | 219167930 | 219168044 |
| ENSE00003537893 | 219163388 | 219163555 |
| ENSE00003539620 | 219169029 | 219169102 |
| ENSE00003583612 | 219164233 | 219164338 |
| ENSE00003635030 | 219168195 | 219168318 |
| ENSE00003789532 | 219168652 | 219168833 |
| ENSE00003899509 | 219161465 | 219162204 |
Expression profiles
Bgee: expression breadth ubiquitous, 170 present calls, max score 98.74.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1098 / max 63.2224, expressed in 14 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 34023 | 0.0616 | 11 |
| 34024 | 0.0482 | 12 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| kidney epithelium | UBERON:0004819 | 98.74 | gold quality |
| ileal mucosa | UBERON:0000331 | 98.05 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 89.72 | gold quality |
| tibialis anterior | UBERON:0001385 | 86.90 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 86.58 | gold quality |
| cortex of kidney | UBERON:0001225 | 86.21 | gold quality |
| kidney | UBERON:0002113 | 85.53 | gold quality |
| pancreatic ductal cell | CL:0002079 | 84.79 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 83.57 | gold quality |
| renal medulla | UBERON:0000362 | 82.30 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 81.55 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 81.40 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 81.37 | gold quality |
| small intestine | UBERON:0002108 | 80.85 | gold quality |
| metanephros cortex | UBERON:0010533 | 80.41 | gold quality |
| jejunal mucosa | UBERON:0000399 | 80.34 | gold quality |
| duodenum | UBERON:0002114 | 80.26 | gold quality |
| adult organism | UBERON:0007023 | 79.63 | gold quality |
| upper arm skin | UBERON:0004263 | 76.99 | gold quality |
| transverse colon | UBERON:0001157 | 76.08 | gold quality |
| metanephros | UBERON:0000081 | 75.83 | gold quality |
| right coronary artery | UBERON:0001625 | 74.60 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 74.56 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 74.46 | gold quality |
| jejunum | UBERON:0002115 | 74.44 | gold quality |
| right lobe of liver | UBERON:0001114 | 73.96 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 73.65 | gold quality |
| deltoid | UBERON:0001476 | 73.63 | silver quality |
| gingival epithelium | UBERON:0001949 | 73.44 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 73.06 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-99795 | no | 7.72 |
| E-ANND-3 | no | 1.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting SLC23A3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-4530 | 99.69 | 66.47 | 1509 |
| HSA-MIR-1251-3P | 99.64 | 67.21 | 1408 |
| HSA-MIR-3609 | 99.52 | 69.89 | 2587 |
| HSA-MIR-548AH-5P | 99.52 | 69.73 | 2626 |
| HSA-MIR-216A-5P | 99.50 | 68.02 | 1288 |
| HSA-MIR-766-3P | 99.47 | 65.24 | 1811 |
| HSA-MIR-5589-3P | 99.29 | 68.30 | 1443 |
| HSA-MIR-4685-5P | 99.25 | 65.99 | 1563 |
| HSA-MIR-6837-5P | 99.25 | 65.47 | 1632 |
| HSA-MIR-5001-3P | 98.91 | 67.28 | 1394 |
| HSA-MIR-4712-3P | 98.52 | 65.39 | 822 |
| HSA-MIR-338-3P | 98.14 | 67.38 | 1137 |
| HSA-MIR-4797-3P | 97.48 | 67.14 | 989 |
| HSA-MIR-664B-5P | 96.74 | 67.50 | 509 |
| HSA-MIR-339-5P | 96.73 | 66.01 | 820 |
| HSA-MIR-1256 | 95.44 | 66.33 | 784 |
| HSA-MIR-6753-5P | 94.70 | 64.08 | 470 |
| HSA-MIR-1296-5P | 93.94 | 67.71 | 305 |
| HSA-MIR-1537-3P | 90.51 | 63.57 | 105 |
Literature-anchored findings (GeneRIF, showing 2)
- In the course of differentiation, the most pronounced changes in the expression levels were observed for the mRNAs that encode SLC30A10 and SLC23A3 transporters. Their increase correlated with an increase in the apical membrane area, indicating that SLC30A10 and SLC23A3 mRNA levels assessed by qRT-PCR may be employed as cell differentiation biomarkers in Caco-2 models. (PMID:30113032)
- SLC23A3 is a renal hypoxanthine transporter. (PMID:35094660)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc23a3 | ENSDARG00000088891 |
| mus_musculus | Slc23a3 | ENSMUSG00000026205 |
| rattus_norvegicus | Slc23a3 | ENSRNOG00000018266 |
| caenorhabditis_elegans | WBGENE00008252 | |
| caenorhabditis_elegans | WBGENE00011593 | |
| caenorhabditis_elegans | WBGENE00011595 | |
| caenorhabditis_elegans | WBGENE00011596 | |
| caenorhabditis_elegans | WBGENE00020004 | |
| caenorhabditis_elegans | WBGENE00021994 |
Paralogs (2): SLC23A2 (ENSG00000089057), SLC23A1 (ENSG00000170482)
Protein
Protein identifiers
Solute carrier family 23 member 3 — Q6PIS1 (reviewed: Q6PIS1)
Alternative names: HPC E2-binding protein 3, Na(+)/L-ascorbic acid transporter 3, Sodium-dependent vitamin C transporter 3
All UniProt accessions (4): A0A0A0MSG3, C9JQ03, H7C2A2, Q6PIS1
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a sodium-dependent hypoxanthine transporter. May show xanthine-hypoxanthine exchange activity.
Subcellular location. Membrane.
Similarity. Belongs to the nucleobase:cation symporter-2 (NCS2) (TC 2.A.40) family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6PIS1-1 | 1 | yes |
| Q6PIS1-2 | 2 | |
| Q6PIS1-5 | 3 |
RefSeq proteins (3): NP_001138361, NP_001138362, NP_653313 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006043 | NCS2 | Family |
Pfam: PF00860
Catalyzed reactions (Rhea), 1 shown:
- hypoxanthine(out) + Na(+)(out) = hypoxanthine(in) + Na(+)(in) (RHEA:76279)
UniProt features (35 total): topological domain 13, transmembrane region 12, compositionally biased region 3, region of interest 2, splice variant 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6PIS1-F1 | 75.79 | 0.42 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 69 (showing top):
HNF4_DR1_Q3, RYTAAWNNNTGAY_UNKNOWN, HNF4_01, PPAR_DR1_Q2, PPARA_01, GOBP_TRANSMEMBRANE_TRANSPORT, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, WGTTNNNNNAAA_UNKNOWN, COUP_DR1_Q6, RASHI_RESPONSE_TO_IONIZING_RADIATION_1, GOMF_TRANSPORTER_ACTIVITY, MIKKELSEN_IPS_LCP_WITH_H3K27ME3, GOBP_NUCLEOBASE_TRANSPORT, SUPT16H_TARGET_GENES, MIR4731_5P
GO Biological Process (2): hypoxanthine transport (GO:0035344), transmembrane transport (GO:0055085)
GO Molecular Function (1): transmembrane transporter activity (GO:0022857)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| purine nucleobase transport | 1 |
| transport | 1 |
| cellular process | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
498 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC23A3 | SNRPF | P62306 | 505 |
| SLC23A3 | RER1 | O15258 | 478 |
| SLC23A3 | CHPT1 | Q8WUD6 | 470 |
| SLC23A3 | SLC16A9 | Q7RTY1 | 470 |
| SLC23A3 | BCAS3 | Q9H6U6 | 462 |
| SLC23A3 | GSTA5 | Q7RTV2 | 420 |
| SLC23A3 | SLC17A4 | Q9Y2C5 | 419 |
| SLC23A3 | FDXACB1 | Q9BRP7 | 404 |
| SLC23A3 | RGS14 | O43566 | 400 |
| SLC23A3 | SLC5A9 | Q2M3M2 | 380 |
| SLC23A3 | MFSD11 | O43934 | 377 |
| SLC23A3 | TEX22 | C9J3V5 | 370 |
| SLC23A3 | CNPPD1 | Q9BV87 | 368 |
| SLC23A3 | SLC7A4 | O43246 | 357 |
| SLC23A3 | LRRC1 | Q9BTT6 | 349 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC23A3 | IGF1R | psi-mi:“MI:0915”(physical association) | 0.400 |
| SLC23A3 | PRODH | psi-mi:“MI:0915”(physical association) | 0.400 |
| SLC23A3 | PGRMC2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): PRODH (Affinity Capture-MS), PRODH (Affinity Capture-MS), PGRMC2 (Affinity Capture-MS), RETSAT (Affinity Capture-MS), SSR1 (Affinity Capture-MS), SSR4 (Affinity Capture-MS), SLC23A3 (Affinity Capture-Western)
ESM2 similar proteins: A6NGC4, A6NKX4, A6NM10, F1NZP5, O96011, P0C242, P27544, P27545, Q0VCY6, Q2TBI8, Q3SYU3, Q4V8E5, Q5F2F2, Q5JZQ7, Q5RFI0, Q5U2T1, Q5U419, Q6AYM9, Q6GQT6, Q6PIS1, Q6TCG5, Q6UXD7, Q6UXT9, Q71RH2, Q7TNV1, Q7Z403, Q80ZE4, Q863Y8, Q86WI3, Q8BMT9, Q8CHK3, Q8IU68, Q8IXF9, Q8N9H8, Q8TBR7, Q8VC26, Q8WUG5, Q96N66, Q99640, Q99JT6
Diamond homologs: B0JZG0, O04472, P93039, Q0WPE9, Q27GI3, Q3E7D0, Q41760, Q60850, Q6PIS1, Q6SZ87, Q8GZD4, Q8RWE9, Q8VZQ5, Q94C70, Q9EPR4, Q9SHZ3, Q9UGH3, Q9UHI7, Q9WTW7, Q9WTW8, Q9Z2J0, A0A2A5JY22, O32139, O32140, P0AGM9, P0AGN0, P0AGN1, P0AGN2, P42086, P50487, P67444, P67445, P67446, Q46821, P45117, Q9CPL9, Q3E956
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 67 |
| Likely benign | 5 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2167 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:219163383:CCTA:C | donor_loss | 1.0000 |
| 2:219163384:CTACC:C | donor_loss | 1.0000 |
| 2:219163385:TAC:T | donor_loss | 1.0000 |
| 2:219163386:A:AT | donor_loss | 1.0000 |
| 2:219163514:C:CT | acceptor_gain | 1.0000 |
| 2:219163515:A:T | acceptor_gain | 1.0000 |
| 2:219162104:CA:C | donor_gain | 0.9900 |
| 2:219162121:C:CA | donor_gain | 0.9900 |
| 2:219163381:CACCT:C | donor_loss | 0.9900 |
| 2:219163382:ACCTA:A | donor_loss | 0.9900 |
| 2:219163385:TACC:T | donor_loss | 0.9900 |
| 2:219163514:C:T | acceptor_gain | 0.9900 |
| 2:219163517:C:CT | acceptor_gain | 0.9900 |
| 2:219163563:A:C | acceptor_gain | 0.9900 |
| 2:219163386:A:AC | donor_gain | 0.9800 |
| 2:219163387:C:CC | donor_gain | 0.9800 |
| 2:219163411:T:TA | donor_gain | 0.9800 |
| 2:219163556:C:CA | acceptor_loss | 0.9800 |
| 2:219163557:T:A | acceptor_loss | 0.9800 |
| 2:219163563:A:AC | acceptor_gain | 0.9800 |
| 2:219165418:CTCAC:C | acceptor_gain | 0.9800 |
| 2:219165420:CACCT:C | acceptor_loss | 0.9800 |
| 2:219165421:ACC:A | acceptor_loss | 0.9800 |
| 2:219165423:C:CA | acceptor_loss | 0.9800 |
| 2:219165423:C:T | acceptor_loss | 0.9800 |
| 2:219165424:T:A | acceptor_loss | 0.9800 |
| 2:219168695:C:A | donor_gain | 0.9800 |
| 2:219161957:C:A | donor_gain | 0.9700 |
| 2:219162292:AACTT:A | donor_loss | 0.9700 |
| 2:219162293:ACTT:A | donor_loss | 0.9700 |
AlphaMissense
3857 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:219163470:A:C | N453K | 0.973 |
| 2:219163470:A:T | N453K | 0.973 |
| 2:219169373:G:C | F118L | 0.964 |
| 2:219169373:G:T | F118L | 0.964 |
| 2:219169375:A:G | F118L | 0.964 |
| 2:219169571:G:C | S90R | 0.962 |
| 2:219169571:G:T | S90R | 0.962 |
| 2:219169573:T:G | S90R | 0.962 |
| 2:219165377:C:T | G320D | 0.956 |
| 2:219165202:G:C | S378R | 0.950 |
| 2:219165202:G:T | S378R | 0.950 |
| 2:219165204:T:G | S378R | 0.950 |
| 2:219165378:C:G | G320R | 0.946 |
| 2:219165247:A:C | S363R | 0.940 |
| 2:219165247:A:T | S363R | 0.940 |
| 2:219165249:T:G | S363R | 0.940 |
| 2:219168808:C:T | G173E | 0.938 |
| 2:219162313:T:A | E508V | 0.936 |
| 2:219169523:G:C | S106R | 0.936 |
| 2:219169523:G:T | S106R | 0.936 |
| 2:219169525:T:G | S106R | 0.936 |
| 2:219169557:C:T | G95D | 0.932 |
| 2:219163513:C:T | G439E | 0.917 |
| 2:219165223:G:C | S371R | 0.917 |
| 2:219165223:G:T | S371R | 0.917 |
| 2:219165225:T:G | S371R | 0.917 |
| 2:219168809:C:G | G173R | 0.917 |
| 2:219168809:C:T | G173R | 0.917 |
| 2:219163443:G:C | F462L | 0.915 |
| 2:219163443:G:T | F462L | 0.915 |
dbSNP variants (sampled 300 via entrez): RS1000036236 (2:219161146 C>T), RS1000053654 (2:219162936 A>G,T), RS1000653064 (2:219164177 C>G,T), RS1001454482 (2:219169581 A>G), RS1001567573 (2:219170039 G>A), RS1001784899 (2:219171194 T>C), RS1002056794 (2:219165544 C>G,T), RS1002111016 (2:219162708 A>G), RS1002415404 (2:219164047 G>C), RS1002655110 (2:219167268 TTAAA>T,TTAAATAAA), RS1003691376 (2:219165453 C>T), RS1003782567 (2:219162791 G>A), RS1003835007 (2:219162530 C>G), RS1004054723 (2:219167730 A>G), RS1004130531 (2:219165798 C>G,T)
Disease associations
OMIM: gene MIM:620339 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000175_19 | Height | 1.000000e-06 |
| GCST002702_34 | Height | 1.000000e-11 |
| GCST008163_280 | Height | 1.000000e-06 |
| GCST011816_2 | Vitamin C levels | 2.000000e-30 |
| GCST012226_195 | Waist circumference adjusted for body mass index | 5.000000e-08 |
| GCST012226_197 | Waist circumference adjusted for body mass index | 2.000000e-10 |
| GCST90002392_175 | Mean corpuscular volume | 2.000000e-09 |
| GCST90020028_715 | Hip circumference adjusted for BMI | 1.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0600003 | vitamin C measurement |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC23 family of ascorbic acid transporters
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tetrachlorodibenzodioxin | affects expression | 2 |
| aristolochic acid I | increases expression | 1 |
| methylmercuric chloride | increases expression | 1 |
| propionaldehyde | increases expression | 1 |
| 2,5,2’,5’-tetrachlorobiphenyl | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | decreases expression | 1 |
| Arbutin | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Cisplatin | decreases expression, affects cotreatment | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Rifampin | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | affects cotreatment, increases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4EQ | 1321N1-SLC23A3-KO-c6 | Cancer cell line | Male |
| CVCL_D4ER | 1321N1-SLC23A3-KO-c7 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.